Two non-coding regulatory SNPs in FGFR2 affect binding of the transcription factors Oct-1/Runx2 and C/EBPβ, leading to an increased expression of FGFR2 in the rarer homozygous genotypes which have increased breast cancer risk [12]. This evidence concerns the gene FGFR2 and breast cancer.